Effect of losartan on haemoglobin concentration in renal transplant recipients--a retrospective analysis

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
D DuclouxJ M Chalopin

Abstract

To evaluate the effect of the angiotensin II type 1 receptor antagonist, losartan, on post-transplant erythrocytosis. We retrospectively analyzed the influence of losartan therapy on haemoglobin levels of renal transplant recipients. Twenty-eight patients who received losartan therapy to control hypertension were divided into two groups. In 10 patients, losartan therapy was initiated after treatment with ACE inhibitors which was discontinued due to adverse reactions (Group A). Group B consisted of 18 patients treated with losartan who had never received ACE inhibitors. There was no difference in mean haemoglobin concentration and haematocrit between the two groups before the onset of losartan therapy. In Group B, mean haemoglobin concentration and haematocrit decreased from 137 +/- 20 g/l and 0.4 at the start of losartan therapy to 120 +/- 16 g/l (P < 0.0005) and 0.35 (P < 0.0005), respectively 3 months later. In Group A, neither haemoglobin nor haematocrit differed between the onset of losartan therapy and the end of the study. Serum creatinine increased from 158 mumol/l +/- 78 to 172 mumol/l +/- 80 in Group B (P < 0.005), but remained stable in Group A. Plasma protein concentrations remained stable in each group and there was...Continue Reading

Citations

Sep 7, 2001·Transplantation·A L Kamper, A H Nielsen
Dec 26, 2001·Current Opinion in Nephrology and Hypertension·Giuseppe Remuzzi, Norberto Perico
Sep 5, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Y Le MeurV Praloran
Jun 10, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A K Abu-AlfaM J Bia
Jun 17, 2004·British Journal of Haematology·William B StrawnCarlos M Ferrario
Nov 9, 2005·Clinical Cardiology·Sujethra VasuWilliam E Lawson
Oct 23, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Aug 5, 1998·Lancet·A SchwarzbeckU Hällfritzsch
Dec 23, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·J CalviñoD Sánchez-Guisande
Apr 2, 2005·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Renee S RichmondWilliam B Strawn
Dec 29, 2000·American Journal of Hypertension·A U KlingbeilR E Schmieder
Aug 28, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·P J GarrettT R Lappin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.